HERNANDEZ MARTINEZ, JUAN MANUEL

HERNANDEZ MARTINEZ, JUAN MANUEL

CIENCIAS MÉDICAS · Nivel 1

Immunotherapy Targeted Therapies Precision Medicine Thoracic Oncology Clinical Trials Non-small-cell lung cancer

Desde 2018 es Professor en Universidad Nacional Autónoma de México

Dr. Juan-Manuel Hernandez-Martinez is a leading cancer biologist and medical scientist at the Instituto Nacional de Cancerología, specializing in lung cancer diagnostics, biomarkers, and targeted therapies. His translational research bridges molecular insights with clinical outcomes, advancing precision medicine in thoracic...

Dr. Juan-Manuel Hernandez-Martinez is a leading cancer biologist and medical scientist at the Instituto Nacional de Cancerología, specializing in lung cancer diagnostics, biomarkers, and targeted therapies. His translational research bridges molecular insights with clinical outcomes, advancing precision medicine in thoracic oncology. A dedicated educator in oncology and pharmacology, he combines rigorous methodology with a critical eye for clarity, structure, and evidence. His scholarly work is grounded in impact—reshaping how cancer is diagnosed and treated across Latin America and beyond.

Leer más

Perfil académico

Nombre JUAN MANUEL HERNANDEZ MARTINEZ
Área MEDICINA Y CIENCIAS DE LA SALUD
Campo CIENCIAS MÉDICAS
Disciplina INVESTIGACIÓN CLÍNICA
Especialidad INVESTIGACION CLINICA
CVU 256083
Institución
Dependencia NO APLICA
Entidad NO APLICA
Nivel 1
Vigencia Inicio: 01/01/2026
Fin: 31/12/2030

Publicaciones ORCID

2026
Progression phenotypes to anti–PD-(L)1 therapy and subsequent management of patients with metastatic NSCLC: A real-world cohort study Cancer Treatment and Research Communications
2025
Immune hemolytic anemia associated with the use of immune checkpoint inhibitors: a scoping review Frontiers in Immunology
Narrowing the Gap: Understanding Lung Cancer Care Intervals and Their Barriers in Latin American Low and Middle-Income Countries Archives of Medical Research
2024
Real-World Survival Outcomes in Non–Small Cell Lung Cancer: The Impact of Genomic Testing and Targeted Therapies in a Latin American Middle-Income Country JCO Global Oncology
Molecular cloning, functional characterization and differential expression of two novel GABAAR-like subunits from red swamp crayfish Procambarus clarkii European Journal of Neuroscience
Prognostic Impact of Nectin-like Molecule-5 (CD155) Expression in Non-Small Cell Lung Cancer Journal of Thoracic Oncology
2023
Re-irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index Cancer Medicine
Somatic and germline ATM variants in non-small-cell lung cancer: Therapeutic implications Critical Reviews in Oncology/Hematology
2022
Targeted therapies and utility of the Lung-molGPA in non-small-cell lung cancer patients with brain metastases Oncology
2021
Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first- or second-generation EGFR-TKIs Cancer Biomarkers